Medicine and Dentistry
Cohort Analysis
100%
Symptom
85%
COVID-19
72%
Rheumatoid Arthritis
70%
Atrial Fibrillation
66%
Diseases
60%
Out of Hospital Cardiac Arrest
59%
Quality of Life
57%
Eosinophilic Esophagitis
56%
Systematic Review
55%
Cross Sectional Study
49%
Intensive Care Unit
46%
Observational Study
46%
Placebo
46%
Infection
42%
Prevalence
42%
Diabetes
41%
Magnetic Resonance Imaging
38%
Recurrent Disease
34%
Cardiac Magnetic Resonance Imaging
33%
Diagnosis
31%
Malignant Neoplasm
31%
Biological Marker
31%
Cardiovascular Disease
30%
Cannabis
29%
Odds Ratio
29%
Heart Failure
29%
Severe Acute Respiratory Syndrome Coronavirus 2
29%
Schistosomiasis
28%
Cardiovascular System
28%
Gut Microbiota
27%
Childbirth
26%
Rheumatic Disease
26%
Adolescent
26%
Emergency Department
25%
Plummer-Vinson Syndrome
25%
Hazard Ratio
23%
Randomized Controlled Trial
23%
Medicine
22%
Apoplexy
21%
Phototherapy
21%
Proportional Hazards Model
21%
Symptomatic Treatment
21%
Heart Arrest
20%
Spontaneous Abortion
20%
Randomized Clinical Trial
20%
Electrocardiogram
19%
Congestive Heart Failure
19%
Colorectal Cancer
19%
Gout
19%
Myocardial Infarction
18%
Rehabilitation Engineering
18%
Premature Labor
18%
Athletes
17%
Geriatrics
17%
Intensive Care
16%
Neonatal Hyperbilirubinemia
16%
All Cause Mortality
16%
Neonates
16%
Anemia
16%
Clinician
16%
Cerclage
16%
Recurrence Risk
16%
Clinical Trial
16%
Second Trimester Pregnancy
16%
Triage
15%
Thromboembolism
15%
Disease Activity
15%
Primary Health Care
15%
Major Depressive Episode
15%
Urinary System
15%
Diagnostic Delay
14%
Schistosoma
14%
Circulating Tumor DNA
14%
Lichen Sclerosus
14%
Delirium
14%
Psychoactive Drug
14%
Hip Fracture
14%
Patient with Type 2 Diabetes
14%
Biosimilar
14%
Tendinosis
14%
Gestational Diabetes
14%
Knee Pain
14%
Colorectal Carcinoma
14%
Coronary Computed Tomography Angiography
14%
Awareness
14%
ICD-10
14%
Medical Record
14%
Population
13%
Biological Product
13%
Activities of Daily Living
13%
Chronic Pancreatitis
13%
Cognition
13%
Logistic Regression Analysis
13%
Biopsy
13%
Mortality Rate
13%
Patient Characteristics
13%
Neonatal Infant
12%
Bleeding
12%
Patient with Diabetes
12%
Keyphrases
Denmark
51%
Atrial Fibrillation
39%
Confidence Interval
35%
COVID-19
33%
Out-of-hospital Cardiac Arrest
28%
Eosinophilic Esophagitis
24%
Hospital Admission
23%
Diabetes
23%
Intensive Care Unit Patients
17%
Rheumatoid Arthritis
16%
Type 1 Diabetes Mellitus (T1DM)
16%
All-cause Mortality
15%
30-day Survival
15%
Cardiovascular Disease
14%
Register Study
14%
Glycemic Control
14%
Prospective Cohort Study
14%
Patients with Diabetes
14%
Randomized Controlled Trial
14%
National Cohort Study
13%
Cardiovascular Mortality
12%
Survivors
12%
Odds Ratio
12%
Hemoglobin A1c (HbA1c)
12%
Severe Coronavirus Disease 2019
12%
Chronic Obstructive Pulmonary Disease
12%
Short-term Mortality
12%
Nationwide Registers
11%
Incidence Rate
11%
Comorbidity
11%
Population-based
11%
Placebo
10%
Type I Diabetes
10%
Female Genital Schistosomiasis
10%
Schistosoma
10%
Hospitalization
10%
Hazard Ratio
9%
Fluid Overload
9%
Coronavirus Diseases 2019 Lockdown
9%
Chin Tuck against Resistance
9%
Atrial Fibrillation or Flutter
9%
Nationwide Observational Study
9%
Socioeconomic Differences
9%
Catheter-associated Urinary Tract Infection (CAUTI)
9%
Plasma Potassium
9%
Patellar Tendinopathy
9%
Male Genital Schistosomiasis
9%
Bacterial Vaginosis
9%
Not in Education
9%
Without Diabetes
9%
Chronic Pancreatitis
9%
Randomized Clinical Trial
9%
Lipid Clinic
9%
Homozygous Familial Hypercholesterolemia (HoFH)
9%
Gout Treatment
9%
Length of Stay
9%
Potassium
8%
Mortality Risk
8%
Procalcitonin
8%
Machine Learning Models
8%
Heart Failure
7%
Return of Spontaneous Circulation
7%
High Risk
7%
Intervention Group
7%
Cervical Lesions
7%
Intensive Care Unit
7%
Thromboembolism
7%
13C Pyruvate
7%
Health Literacy
7%
Nationwide Registry
7%
Risk of Ischemic Stroke
6%
Patients with Heart Failure
6%
Lockdown
6%
Absolute Risk
6%
Registry-based
6%
Patient Perspective
6%
Dysphagia
6%
Self-efficacy
6%
Young People
6%
Nave
6%
Healthcare System
6%
Systematic Literature Review
6%
No Significant Difference
6%
Early Identification
6%
Mortality Rate
6%
Patients at Risk
6%
Patient Identification
6%
Ultrasound-guided Injection
6%
Temporal Trends
5%
Clinical Practice Guidelines
5%
Stroke Risk
5%
Hypokalemia
5%
Hypertension
5%
Hyperkalemia
5%
Placebo-controlled Trial
5%
Usual Care
5%
Male Sex
5%
Literature Search
5%
Histological Remission
5%
Type 2 Diabetes Mellitus (T2DM)
5%